Providers are again urging HHS to step in after Sanofi told 340B providers they need to share claims data for 340B drugs dispensed through contract pharmacies or the drug manufacturer will stop shipping the discounted drugs to those pharmacies. Sanofi’s move follows similar action by Merck Sharpe & Dohme Corp . The Health Resources and Services Administration told Inside Health Policy the agency is aware of Merck and Sanofi’s recent communications to 340B providers about contract pharmacies, and “is...